Immunology News and Research

Latest Immunology News and Research

Researchers find mugwort pollen as major source of airborne endotoxins

A wide range of airborne substances can cause respiratory problems for asthma sufferers. These include bacteria and their components, which can trigger inflammations.

19 Jul 2018

Mother's microbiome determines offspring's risk of developing autism

The risk of developing autism-spectrum disorders is determined by the mother's microbiome - the collection of microorganisms that naturally live inside us - during pregnancy, new research from the University of Virginia School of Medicine suggests.

18 Jul 2018

Allergic responses may help protect the skin against cancer, research suggests

The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

18 Jul 2018

Why men may recover more quickly from influenza infections than women

Men may recover more quickly from influenza infections because they produce more of a key lung-healing protein, a study from scientists at Johns Hopkins Bloomberg School of Public Health suggests.

17 Jul 2018

Researchers detect presence of IgE antibodies after kidney transplantation

Many donor kidneys that are transplanted are rejected by the recipient within ten years after transplantation.

17 Jul 2018

Immune T cells are built to react as fast as possible, shows study

Without T cells, we could not survive. They are a key component of our immune system and have highly sensitive receptors on their surface that can detect pathogens.

17 Jul 2018

Burdensome symptoms of eczema can lead to impaired quality of life, shows study

If you've never suffered from eczema, also known as Atopic Dermatitis, you probably aren't aware of the negative impact it can have on quality of life.

16 Jul 2018

Scientists identify structural and functional differences in human immune-surveillance protein

The human body is built for survival. Each one of its cells is closely guarded by a set of immune proteins armed with nearly foolproof radars that detect foreign or damaged DNA.

13 Jul 2018

Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes

For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on an assortment of expensive medicines and devices to stay healthy. Test strips. Needles. A glucose meter. Insulin.

13 Jul 2018

Immunotherapies may increase overall survival in patients with melanoma brain metastases

Among patients with cutaneous melanoma who had brain metastases (MBM), first-line treatment with a checkpoint inhibitor was associated with a 1.4-fold increase in median overall survival, according to results from a national cohort.

13 Jul 2018

Researchers decipher key component behind rising epidemic of pathogens in West Africa

A research team from several institutions being led by the University of California San Diego has deciphered a key component behind a rising epidemic of pathogens that the World Health Organization (WHO) recently added to its list of critical emerging diseases.

13 Jul 2018

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

12 Jul 2018

Associate professor receives $1 million grant for disease research

Associate Professor Janelle Ayres is the recipient of a $1 million grant from the W. M. Keck Foundation to study new ways to treat deadly infections including sepsis and the flu, both of which require novel therapies beyond antibiotics and antivirals to effectively combat.

12 Jul 2018

Streck ARM-D Kits detect more antibiotic resistance than comparable tests

Streck, Inc., received great interest in Streck ARM-D Kits after its poster presentation on improved methodology for detection of antibiotic resistance in Gram-negative bacteria at ECCMID 2018 in Madrid.

12 Jul 2018

Aurinia’s Phase 2 trial evaluates voclosporin ophthalmic solution for treating dry eye syndrome

Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).

12 Jul 2018